Catalyst Wire Dossier Catalyst Wire Dossier

TNP-2092

· TenNor Therapeutics (Suzhou) Limited
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for TNP-2092, covering 2023-12-01 to 2026-03-05. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1/2 Study to Evaluate the Safety, PK and Efficacy of TNP-2092 Administered Via IA Injection in PJI Participants [Phase 1, Phase 2]

See pricing